Strategic innovations will help prevent HIV transmission from mothers to children, high-level meeting attendees state

At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries -- home to 90 percent of new HIV infections among children --" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports. "The priority countries are Angola, Botswana, Burundi, Cameroon, Chad, Cote d'Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe," the news service notes.

Attendees included representatives of UNAIDS and PEPFAR, "which together co-chair the Global Steering Group on EMTCT," according to the news service (4/21). "The April meeting is to be followed by a leadership forum on 'Innovation for the Elimination of Mother to Child Transmission' on 22 July in Washington, D.C., which will showcase technologies and approaches by individual countries to accelerate results, especially within the most disadvantaged communities," a UNICEF Mozambique article notes (4/20).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17